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Abstract 1-Benzyl-1,2,3,4-tetrahydroisoquinoline (1BnTIQ)
was shown to be neurotoxic to the dopaminergic neurons, and
thus it was proposed to be an endogenous risk factor leading to
Parkinson’s disease. In order to better understand the molec-
ular mechanisms of 1BnTIQ—produced toxicity, we examined
the impact of different concentrations of 1BnTIQ (50, 100, and
500 lM) on glutamate-induced apoptotic pathway. We mea-
sured the markers of apoptosis, such as caspase-3 activity,
lactate dehydrogenase release, and mitochondrial membrane
potential. Molecular data were supported at the cellular level
by calcein AM and Hoechst 33342 staining. The obtained data
demonstrated concentration-dependent effects of 1BnTIQ
opposing apoptosis, and evidenced that 1BnTIQ in a low
concentration (50 lM) exhibited neuroprotective activity,
whereas in 10 times higher concentration (500 lM) might be
neurotoxic, and significantly intensified glutamate-induced
increase in apoptosis markers. Additionally, using an ex vivo
molecular study we indicated that both acute and chronic
administration of 1BnTIQ did not affect the level of alpha
synuclein and tyrosine hydroxylase protein in the rat substantia
nigra. Summarizing the studies, we suggest that 1BnTIQ is a
rather weak endogenous neurotoxin; however, it should be
taken into account that in higher lmoles concentrations, it can
initiate apoptosis in the central nervous system and may be
involved in the etiopathology of neurodegenerative diseases.
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Introduction
The programed cell death (apoptosis) is a biological pro-
cess in which unwanted and/or damaged cells are killed, so
that the organism could maintain homeostasis. The apop-
tosis process is a characteristic not only of normal devel-
opment but also of numerous neurodegenerative diseases
and neurological conditions, such as Parkinson’s disease
(PD), Alzheimer’s disease (AD), Huntington’s disease, and
stroke (Bamberger and Landreth 2002; Jenner 2003;
Mattson 2003; McLaughlin et al. 1998; Morishima et al.
2001). Keep in mind that in the neurodegenerative dis-
eases, neuronal cells death occurs not only via apoptosis
but also in the necrosis. Apoptosis mainly affects the cell
nucleus and is related to specific DNA fragmentation
which results in apoptotic body formation and individual
cell death without inflammatory response to damage
(Honda et al. 2001). Apoptotic cells may be characterized
by specific morphological and biochemical changes,
including cell shrinkage, chromatin condensation, and in-
ternucleosomal cleavage of genomic DNA (Kajta et al.
2004). At the molecular level, apoptosis is regulated by the
activation of the caspase cascade, which depends on non-
specific insults leading to calcium influx into the cytoplasm
and reduction of mitochondrial membrane potential
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(internal pathway). Alternative apoptotic pathway (external
pathway) is mediated through death receptors (Kajta et al.
2004). Caspase-3 has been proposed to be a crucial exe-
cutioner protease of the apoptotic cascade (Kuida et al.
1996; Pompeiano et al. 2000). Although apoptosis is usu-
ally a caspase-dependent process, it may also be unrelated
to caspases, but mediated by other enzymes, such as cal-
pains, which accompany programed cell death during
neuronal degeneration.
A number of in vitro studies have demonstrated that
glutamate is a potent neurotoxin capable of destroying
neurons by apoptosis (Froissard and Duval 1994; Behl
et al. 1995; Kajta et al. 2007, 2013). In this way, glutamate
represents a good model for the study of apoptosis. In
primary cortical cells, glutamate-induced cell death
involves upregulation of caspase-3 and its activation via
the caspase-dependent pathway involving mitochondrial
signaling (Zhang and Bhavnani 2005). Possible factors
responsible for the neuron degeneration include: oxidative
stress, mitochondrial dysfunctions, protein mishandling,
apoptosis, and inflammation (Gandhi and Wood 2005;
Moore et al. 2005; Sas et al. 2007). Dopaminergic brain
structures are particularly sensitive to oxidative stress,
because the dopamine metabolism itself leads to generation
of reactive oxygen species (ROS). ROS generation initiates
mitochondrial-caspase cascade which leads to the activa-
tion of the main effector of apoptosis, i.e., caspase-3
(Hanrott et al. 2006; Bayir et al. 2009).
1-Benzyl-1,2,3,4-tetrahydroisoquinoline (1BnTIQ) is an
endogenous neurotoxin which has been proposed to be one
of the etiological factors of idiopathic PD (Kotake et al.
1995). The concentration of 1BnTIQ in the CSF of par-
kinsonian patients was three times higher than in the CSF
of neurological control subjects (Kotake et al. 1995).
Chronic treatment with 1BnTIQ produced parkinsonian-
like symptoms in rodents and primates (Kotake et al. 1995,
1996). Some evidence demonstrated that 1BnTIQ-induced
cell death via apoptosis, and dose dependently elevated the
level of the pro-apoptotic protein Bax and decreased the
concentration of the antiapoptotic protein Bcl-xl. Addi-
tionally, 1BnTIQ increased the formation of the active
caspase-3 protein fragments (Shavali and Ebadi 2003).
1BnTIQ, which is synthesized endogenously in the brain
and/or is obtained exogenously in the diet, can be taken up
by neurons via DAT. Furthermore, it accumulates in the
dopaminergic neurons and may exert some pathological
effects leading to parkinsonism (Okada et al. 1998). As
previously demonstrated, 1BnTIQ strongly affected dopa-
mine metabolism, and similar to the other exogenous
neurotoxins potentiated MAO-dependent dopamine oxida-
tion and inhibited COMT-dependent O-methylation cata-
bolic pathways (Antkiewicz-Michaluk et al. 2001; Wa˛sik
et al. 2009). What is more, 1BnTIQ might inhibit mono-
amine vesicular transporter2 (VMAT2), and led to an
increase of the oxidative stress by generation of ROS in
dopaminergic neurons (Wa˛sik et al. 2009). In the light of
these data, the question arises whether neurotoxic effect of
1BnTIQ is mainly observed in dopaminergic structures? It
was also interesting to examine whether in vitro effects
correspond with the ex vivo experiments.
The aim of the present study was a systematic analysis
of the effects of different concentrations of 1BnTIQ on




The ex vivo experiments were carried out on male Wistar
rats whose initial body weight was 220–240 g. All animals
had free access to standard laboratory food and tap water,
and were maintained at room temperature (RT) (22 C)
under an artificial light/dark cycle (12/12 h, light on at 7
a.m.).
The rats were administered 1BnTIQ at a dose of 50 mg/
kg intraperitoneally (ip) once or chronically for 14 con-
secutive days. Control rats were treated with an appropriate
solvent. The rats were killed by decapitation 3 h (caspase-3
activity) or 24 h (a-synuclein and tyrosine hydroxylase)
after the last drug injection, and different structures of the
brain were dissected. The experiments were carried out
between 9.00 and 16.00 h.
All procedures were carried out in accordance with the
National Institutes of Health Guide for the Care and Use of
Laboratory Animals and were granted an approval from the
Bioethics Commission as compliant with Polish Law. All
the experimental procedures were approved by the Local
Bioethics Commission of the Institute of Pharmacology,
Polish Academy of Sciences in Krako´w.
Drugs
1BnTIQ hydrochloride was synthesized (according to Can-
non and Webster, 1958) at the Department of Drug Chem-
istry of the Institute of Pharmacology, the Polish Academy of
Sciences in Krako´w. Purity of the compound was verified by
measurement of its melting point; and homogeneity was
assessed on a chromatographic column. The compounds
were dissolved in a 0.9 % NaCl solution. Glutamic acid was
purchased from Sigma-Aldrich (St. Louis, MO, USA),
whereas calcein AM and Hoechst 33342 were purchased
from Molecular Probes (Eugene, OR, USA).
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Primary Hippocampal Cell Cultures
Hippocampal tissues for primary cultures were prepared
from Wistar rat or Swiss mouse embryos (Charles River,
Germany) at 15th–17th day of gestation and were cultured
essentially as described earlier (Junghans and Kappler 1999;
Kajta et al. 2009). Animal care followed official govern-
mental guidelines, and all efforts were made to minimize the
number of animals used and their suffering. All procedures
were carried out in accordance with the National Institutes of
Health Guidelines for the Care and Use of Laboratory Ani-
mals, and were granted an approval from the Bioethics
Commission as compliant with Polish Law (21 August
1997). The cells were suspended in estrogen-free neurobasal
medium supplemented with B27 and plated at a density of
2.5 9 105 cells per cm2 onto poly-ornithine (0.01 mg/ml)-
coated multiwell plates. The cultures were maintained at
37 C in a humidified atmosphere containing 5 % CO2 for
7 days in vitro (DIV) prior to experimentation. The level of
astrocytes, as determined by the content of intermediate fil-
ament protein GFAP (glial fibrillary acidic protein), did not
exceed 10 % for all cultures (Kajta et al. 2004).
Treatment
Primary hippocampal cell cultures were exposed to gluta-
mate (1 mM), 1BnTIQ (50, 100, 500 lM), or glutamate
and 1BTIQ for 24 h. To avoid unspecific effects in our
study, 1BnTIQ was used in the concentrations which did
not affect the control level of caspase-3 activity and lactate
dehydrogenase (LDH) release. All the compounds were
originally dissolved in dimethyl sulfoxide (DMSO), and
then further diluted in culture medium to achieve DMSO
concentrations below 0.1 %.
Identification of Apoptotic Cells
Apoptotic cells were detected by Hoechst 33342-staining
24 h after initial treatment, as described previously (Kajta
et al. 2013). Hippocampal cells cultured on glass cover slips
were washed with 10 mM phosphate-buffered saline (PBS)
and exposed to Hoechst 33342 (0.6 mg/ml), at RT for 5 min.
Cells with bright blue-fragmented nuclei, showing con-
densed chromatin, were identified as apoptotic cells. Quali-
tative analysis was performed using a fluorescence
microscope (Leica Microsystems Wetzlar GmbH, Wetzlar,
Germany) connected to a CoolSnap camera (Vision Systems
GmbH, Puchheim, Germany) with MetaMorph software.
Staining with Calcein AM
Staining with calcein AM was based on intracellular
esterase activity in hippocampal cultures 24 h after initial
treatment (Kajta et al. 2013). In order to block esterase
activity present in the growth media, cells were washed
with PBS. The cells grown on glass cover slips were then
incubated in 2 lM calcein AM in PBS at RT for 10 min.
Cells with bright yellow cytoplasm were identified as liv-
ing cells. A fluorescence microscope (Leica Microsystems
Wetzlar GmbH, Wetzlar, Germany) connected to a Cool-
Snap camera (Vision Systems GmbH, Puchheim, Ger-
many) with MetaMorph software was used for qualitative
analyses.
Assessment of Mitochondrial Membrane Potential
The mitochondrial membrane potential was determined
with the JC-1 Assay Kit, which utilizes a cationic dye
5,50,6,60-tetrachloro-1,10,3,30-tetra-
ethylbenzimidazolylcarbo-cyanine iodide. In healthy cells,
the dye aggregates and stains the mitochondria bright red,
whereas in apoptotic cells, the mitochondrial membrane
potential collapses, and the dye remains in the cytoplasm in
a green fluorescent monomeric form (Hirsch et al. 1998).
The assessment of the loss of mitochondrial membrane
potential, which is a hallmark of apoptosis, was performed
in the hippocampal cultures treated for 6 h with glutamic
acid (1 mM) and 1BnTIQ (50, 500 lM) alone or in com-
bination. Cells were incubated with JC-1 solution for
25 min, and red (550/600 nm) and green (485/535 nm)
fluorescence were measured with an Infinite M1000
microplate reader (Tecan, Austria). The data were analyzed
with I-control software, normalized to the fluorescence in
vehicle-treated cells, and expressed as the red-to-green
fluorescence ratio ± SEM of three to four independent
experiments. The fluorescence of blanks, acting as no
enzyme controls, was subtracted from each value.
Assessment of Caspase-3 Activity
Caspase-3 activity was determined according to Nicholson
et al. (1995), using samples treated for 24 h with glutamate
(1 mM) alone or in combination with the test compound.
The assessment of caspase-3 activity was performed as
previously described (Kajta et al. 2009). Cell lysates were
incubated at 36 C with a colorimetric substrate that is
preferentially cleaved by caspase-3, called Ac-DEVD-pNA
(N-acetyl-asp-glu-val-asp-p-nitro-anilide). The amounts of
p-nitroanilide were monitored continuously over 60 min
with a Multiskan Spectrum Microplate Spectrophotometer
(ThermoLabsystems, Vantaa, Finland). Data were analyzed
with Ascent software, normalized to the absorbance in
vehicle-treated cells, and expressed as percent of con-
trol ± SEM of three to four independent experiments. The
absorbance of blanks, acting as no enzyme controls, was
subtracted from each value.
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Measurement of Lactate Dehydrogenase Activity
To quantify cell death, LDH released from damaged cells
into the cell culture media was measured 24 h after treat-
ment with glutamate and 1BnTIQ (50, 100, 500 lM). LDH
release was measured as previously described (Kajta et al.
2004). Cell-free culture supernatants were collected from
each well and incubated with the appropriate reagent
mixture according to the supplier’s instructions (Cytotox-
icity Detection Kit) at RT for 30–60 min depending on
reaction progress. The intensity of red color formed in the
assay, measured at a wavelength of 490 nm, was propor-
tional to both LDH activity and the number of damaged
cells. Data were normalized to the color intensity from
vehicle-treated cells (100 %) and expressed as percent of
control of three to four independent experiments. The total
LDH release was determined in the cell cultures treated
with 1 % Triton X-100 for 24 h. The total LDH release
reached value of 1.100 ± 0.190 U/h/100 lg protein. In
control cultures, the absolute value of LDH activity was
0.300 ± 0.050 U/h/100 g protein and was similar to that
obtained by Mytilineou et al. (1998).
Western Blot Analysis of a-Synuclein (aSyn) and Tyrosine
Hydroxylase (TH) Protein
Isolated structures (substantia nigra and striatum) origi-
nating from 1-BnTIQ or solvent-treated rats were weigh-
ted, homogenized on ice in 20 volumes of RIPA buffer
(150 mM NaCl, 1.0 % NP-40, 0.5 % sodium deoxycholate,
0.1 % SDS, 50 mM Tris, pH 8.0) with addition of protease
inhibitors mixture (Pierce). Protein concentration in the
supernatants was determined using bicinchoninic acid
protein assay kit (Pierce). Afterward, the samples con-
taining 5 lg of total protein were fractionated by 12 or
10 % sodium dodecyl sulfate–polyacrylamide gel electro-
phoresis (SDS-PAGE), as described previously by Lae-
mmli (1970) and processed to detect a-synuclein or
tyrosine hydroxylase. Proteins from the resolved gels were
then transferred to nitrocellulose membranes (Sigma).
Nonspecific binding sites were blocked overnight at 4 C
by a 3 % BSA in Tris-buffered saline with a 0.5 % Tween
20 (TBS-T) and incubated for 2 h with a mouse mono-
clonal anti-aSyn antibody (BD Transduction Laboratories,
dilution 1:2000) or mouse monoclonal anti-TH antibody
(Millipore, dilution 1:4000) in 1 % BSA at RT. After three
washes in TBS-T, membranes were processed according to
the standard BM Chemiluminescence Western Blotting Kit
protocol (Roche Applied Science). Following immunoblot
visualization, membranes were blocked with a 5 % nonfat
dry milk in TBS for 10 min at RT, and dried on absorbent
filter paper. Afterward, blots were erased in 62.5 mM
TrisCl pH 6.8, 2 % SDS, 100 mM 2-mercaptoethanol for
30 min at 50 C, washed twice with TBS and blocked
overnight with a 5 % nonfat dry milk in TBS at 4 C. As a
control to protein level normalization, erased blots were
processed with mouse monoclonal anti-b-actin antibody
(Santa Cruz Biotechnology, Inc., dilution 1:1000), as
described above.
The amounts of protein per lane as well as antibody
concentrations were optimized in pilot studies so that at
least threefold differences in protein content were linearly
reflected on immunoblots.
The signals were visualized and quantified by the den-
sitometric analysis with the FUJI-LAS 4000 system and
Fuji Multi Gauge software. Results are presented as a
percentage of the control of the analyzed protein: b-actin
ratio ± SEM.
Calculations and Statistics
Statistical tests were performed on raw data expressed as
the mean arbitrary absorbance or fluorescence units per
well containing 50,000 cells (measurements of caspase-3,
LDH, mitochondrial potential). A one-way analysis of
variance (ANOVA) was used to determine overall signifi-
cance. Differences between control and experimental
groups were assessed with the post hoc Neuman–Keuls
test, with the significant differences marked in the fol-
lowing way: *p \ 0.05; **p \ 0.01; ***p \ 0.001 (vs
control group); #p \ 0.05; ##p \ 0.01; ###p \ 0.001 (vs
glutamate group).
Statistical significance of the data from Western blot
analysis was assessed using a one-way ANOVA followed
(if significant) by the Tukey test for post hoc comparison
with the control (saline) group.
Results
The Effects of 1BnTIQ on Glutamate-Induced Caspase-
3 Activity and LDH Release in Hippocampal Cultures
In hippocampal cultures exposed to 1 mM glutamate for
24 h, the activity of caspase-3 increased by 30 %
(p \ 0.001) (Fig. 1). Similar effect was observed in the
presence of glutamate and 1BnTIQ in the low concentra-
tions (50 and 100 lM). In contrast, the highest concen-
tration of 1BnTIQ (500 lM) significantly (p \ 0.001)
intensified the effect of glutamate and produced elevation
of caspase-3 activity by 100 % (Fig. 1).
LDH release increased within the duration of glutamate
treatment by 30 % (p \ 0.01) (Fig. 2). 1BnTIQ in the
lower concentration (50 lM) inhibited glutamate-induced
LDH release, to the control level. 1BnTIQ in the middle
concentration (100 lM) was not active, whereas its highest
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concentration (500 lM) significantly (p \ 0.001) intensi-
fied glutamate-induced release of LDH by 190 % (Fig. 2).
In the cells treated with 50 and 100 lM 1BnTIQ, the
activity of caspase-3 was *110 % (Fig. 1), and LDH
release reached the average value of 101 % (Fig. 2).
Exposure to 500 lM 1BnTIQ produced visible (*130 %),
but also not significant increase in the levels of caspase-3
(Fig. 1) and LDH (Fig. 2).
The Influence of 1BnTIQ on Glutamate-Induced Loss
of Mitochondrial Membrane Potential in Mouse
Hippocampal Cultures
6 h exposure of hippocampal cultures to glutamate (1 mM)
caused an about 70 % loss of mitochondrial membrane
potential in the neuronal cells (p \ 0.001) (Fig. 3). Co-
treatment with 1BnTIQ in concentrations of 50 and
500 lM partially reversed this effect increasing the mito-
chondrial membrane potential to *50 % of the control
value (Fig. 3). The administration of 1BnTIQ in both used
concentrations (50 and 500 lM) alone did not affect the
nonstimulated control levels of the measured parameters
(Fig. 3).
The Influence of 1BnTIQ on Glutamate-Induced
Changes in Calcein AM and Hoechst 33342 Staining
in Hippocampal Cultures
A continuous 24-h exposure of hippocampal cultures to glu-
tamate (1 mM) reduced the density of living cells, as indicated
by the decreased number of cells with light-colored cytoplasm
(Fig. 4b). Treatment with glutamate substantially enhanced the
number of bright fragmented nuclei with condensed chromatin,
which is typical of cells undergoing apoptosis (Fig. 4b).
Co-treatment with 1BnTIQ at 50 lM normalized the
number of healthy living cells and diminished the number of
fragmented nuclei (Fig. 4c). In contrast to this, a higher
concentration of 1BnTIQ (500 lM) did not affect on gluta-
mate-induced changes in calcein AM and Hoechst 33342
staining in the hippocampal cultures (Fig. 4d).
The Effect of Acute and Chronic Administration
of 1BnTIQ on Caspase-3 Activity in the Rat
Hippocampus. An Ex Vivo Study
Acute systemic administration of 1BnTIQ in a dose of
50 mg/kg produced only a slight elevation of the caspase-3
Fig. 1 The effect of 1BnTIQ on glutamate-induced caspase-3
activity in rat hippocampal cultures. Cells were treated either with
glutamate (1 mM) or 1BnTIQ (50, 100 or 500 lM) alone or in
combination. The results are presented as a percentage of control.
Each bar represents the mean of three to four independent experi-
ments ± SEM. The number of replicantes in each experiment ranged
from 5 to 8. ***p \ 0.001 versus control cultures; ###p \ 0.001
versus the cultures exposed to glutamate
Fig. 2 The effect of 1BnTIQ on glutamate-induced release of LDH
in rat hippocampal cultures. Cells were treated either with glutamate
(1 mM) or 1BnTIQ (50, 100 or 500 lM) alone or in combination. The
results are presented as a percentage of control. Each bar represents
the mean of three to four independent experiments ± SEM. The
number of replicantes in each experiment ranged from 5 to 8.
**p \ 0.01 versus control cultures; #p \ 0.05; ###p \ 0.001 versus
the cultures exposed to glutamate
94 Neurotox Res (2014) 25:90–99
123
activity, whereas chronic (14 days) administration of
1BnTIQ induced a significant (p \ 0.05) increase in this
parameter (by *90 %) (Fig. 5).
The Effects of Acute and Chronic 1BnTIQ
Administration on the a-Synuclein Level in the Rat
Substantia Nigra as Measured 24 h After the Last Dose.
An Ex Vivo Study
The data in Fig. 6 demonstrate that both acute and chronic
(14 days) treatment with 1BnTIQ (50 mg/kg i.p.) did not
change the level of a-synuclein in the substantia nigra
measured 24 h after the last dose.
The Effects of Acute and Chronic 1BnTIQ
Administration on the Tyrosine Hydroxylase Level
in the Substantia Nigra as Measured 24 h After the Last
Dose. An Ex Vivo Study
Both acute and chronic 14-day administration of 1BnTIQ
(50 mg/kg i.p.) did not change the level of tyrosine
hydroxylase in the substantia nigra measured 24 h after the
last does (Fig. 7).
Discussion
The main finding of this paper is that 1BnTIQ produced
concentration-dependent opposite effects on markers of
apoptosis evaluated by in vitro studies in primary hippo-
campal cultures of the mouse and the rat. 1BnTIQ in a low
concentration (50 lM) possessed neuroprotective activity,
while in a 10 times higher concentration (500 lM) might
be neurotoxic, and significantly intensified glutamate-
induced neurotoxicity. On the other hand, in vivo chronic
administration of 1BnTIQ did not produce neurotoxic
effects on dopamine neurons in the substantia nigra as
assessed by the levels of two proteins: tyrosine hydroxylase
and alpha-synuclein.
1BnTIQ is an endogenous neurotoxin which has been
proposed to be an etiological factor of PD (Kotake et al.
1995; Antkiewicz-Michaluk et al. 2001). 1BnTIQ can be
formed in vivo in the mammalian brain from phenyleth-
ylamine and phenylacetaldehyde. This compound belongs
to the isoquinoline group and its structure closely resem-
bles the well-known exogenous toxin, MPTP; however, the
potency and mode of action of both these substances are
completely different. While MPTP acts rapidly and pro-
duces irreversible neurotoxic changes even after a single
injection (Burns et al. 1985), 1BnTIQ produces a nonim-
mediate and milder neurotoxic effect (Antkiewicz-Mich-
aluk et al. 2000, 2001; Lorenc-Koci et al. 2004). In the light
of these observations, 1BnTIQ may offer a better model of
PD, exhibiting slowly developing neurodegenerative
changes. In fact, the level of 1BnTIQ in the CSF has been
reported to be three times higher in PD patients than in
control subjects (Kotake et al. 1995).
In the present study, we used the glutamate model of
neurotoxicity to induce apoptosis. A number of in vitro
studies revealed that a high concentration (mM) of gluta-
mate destroyed neurons (Froissard and Duval 1994; Davis
and Maher 19933). Glutamate toxicity involves oxidative
stress and apoptosis (Coyle and Puttfarcken 1993; Nicotera
et al. 1997). Exposure to glutamate has been associated
with an increase in cytosolic Ca2? in the cells (Atlante
et al. 2001). Additionally, a long exposure to glutamate
resulted in permanent damage of mitochondria, which
occurred simultaneously with a high mitochondrial ROS
production (Beal et al. 1997). As shown in this paper,
glutamate in mM concentration significantly elevated the
Fig. 3 The influence of 1BnTIQ on glutamate-induced loss of
mitochondrial membrane potential in mouse hippocampal cultures.
Primary hippocampal cultures were treated with glutamate (1 mM) or
1BnTIQ (50 or 500 lM) alone or in combination, for 6 h. The
mitochondrial membrane potential was detected with JC-1 Assay Kit.
The results were normalized to the fluorescence in vehicle-treated
cells and expressed as red to green fluorescence ratio. Each bar
represents the mean of three to four independent experi-
ments ± SEM. The number of replicantes in each experiment ranged
from 5 to 8. ***p \ 0.001 versus control cultures; #p \ 0.05;
##p \ 0.01 versus the cultures exposed to glutamate
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caspase-3 activity (Fig. 1). In the combined treatment
groups, only the highest concentration of 1BnTIQ
(500 lM) produced potentiation of the glutamate effect on
caspase-3 activity (Fig. 1) and LDH release (Fig. 2) in the
rat hippocampal cultures. Lower concentrations of 1BnTIQ
(50 and 100 lM) did not potentiate the toxic effect of
glutamate or even inhibited the toxicity in the rat hippo-
campus, leading to reduction in the LDH release (Fig. 2).
The results presented in this paper suggest that in the pri-
mary cultures of rodent hippocampus 1BnTIQ may act
differently depending on the applied concentration: show-
ing neuroprotective properties in a lower concentration and
neurotoxic activity in higher concentrations. It should be
mentioned that in contrast to our studies, a majority of
authors investigated the biochemical and molecular
mechanisms of neurotoxicity of 1BnTIQ mainly in
Fig. 4 The influence of
1BnTIQ (50 or 500 lM) on
glutamate-induced (1 mM)
changes in calcein AM (first
column) and Hoechst 33342
(second column) staining in rat
hippocampal cultures, examined
24 h post-treatment. a Control,
b glutamate (1 mM),
c Glutamate (1 mM) ? 1BnTIQ
(50 lM), d Glutamate
(1 mM) ? 1BnTIQ (500 lM).
Cells were cultured on glass
cover slips, washed with 10 mM
PBS, and exposed to 2 lM
calcein AM at RT for 10 min.
Cells were then rewashed and
incubated with Hoechst 33342
(0.6 lg/ml) at RT for 5 min.
Cells with bright fragmented
nuclei showing condensed
chromatin (see arrows) were
identified as undergoing
apoptosis, whereas cells with
light-colored cytoplasm were
identified as living cells.
Hoechst 33342 stain is a cell-
permeant nuclear counterstain
that emits blue fluorescence
when bound to dsDNA. This
dye is often used to distinguish
condensed pycnotic nuclei
(marked by arrows) in apoptotic
cells (Color figure online)
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dopaminergic cells or structures (Kotake et al. 1995; Sha-
vali and Ebadi 2003; Wa˛sik et al. 2009). Now, for the first
time, we have found that 1BnTIQ can destroy nondopam-
inergic structures, e.g., hippocampus. The hippocampus is
composed of different kinds of neurons, viz. it contains a
high proportion of glutamatergic neurons and small amount
of dopaminergic neurons. For this reason, the hippocampus
is a very sensitive structure to the toxic effects of glutamate
and is a good model for investigation of apoptosis. Previ-
ously, different authors who studied the process of apop-
tosis have focused mainly on the dopaminergic system.
Shavali et al. (2004) observed toxic effects of 1BnTIQ
even at low concentrations when they were evaluated in
human dopaminergic SH-SY5Y cells. The authors dem-
onstrated that lower concentrations of 1BnTIQ (1–100 lM)
produced a decrease in reduced glutathione (GSH) and an
increase in alpha-synuclein levels, whereas higher con-
centrations of 1BnTIQ (250 and 500 lM) significantly
elevated ROS levels and decreased ATP content. It is
interesting that in human dopaminergic SH-SY5Y cells, a
protective effect of a low concentrations of 1BnTIQ was
not observed. What is more, our present in vitro data
indicated that 1BnTIQ used in a broad range of concen-
trations (50 up to 500 lM) in primary hippocampal cul-
tures did not affect the mitochondrial membrane potential,
but partially antagonized glutamate-induced loss of mito-
chondrial membrane potential (Fig. 3). It appears that such
discrepancies between our present results and other
authors’ data may be due to different study material where
the proapoptotic effect of 1BnTIQ was examined (human
dopaminergic SH-SY5Y cells and primary hippocampal
cultures). Our present in vitro studies performed on hip-
pocampal primary cultures of both mice and rats clearly
indicate that neurotoxic action of high concentrations of
1BnTIQ occurs via apoptosis. Beyond the assessment of
caspase-3 activity, we also evaluated other markers of
apoptosis, since we performed the identification of apop-
totic cells by Hoechst 33342-staining and by calcein AM
staining in rat hippocampal cultures. We investigated the
effect of 1BnTIQ in two different concentrations: 50 and
500 lM on glutamate-induced (1 mM) pro-apoptotic
action. The results seem agree with the above data for
caspase-3 activity and LDH release. 1BnTIQ in a lower
concentration (50 lM) partially inhibited and in a higher
dose (500 lM) intensified glutamate-induced pro-apoptotic
effect on hippocampal cells (Fig. 4c, d).
In our ex vivo study, we obtained further interesting data
on the mechanism of neurotoxic action of 1BnTIQ after its
Fig. 5 The effect of acute and chronic administration of 1BnTIQ on
caspase-3 activity in the rat hippocampus. An ex vivo study: 1BnTIQ
was administered acute (91) or chronic at dose 50 mg/kg i.p. during
14 consecutive days. The control group was treated with saline. The
rats were decapitated 3 h after last injection. The results are expressed
as the mean ± SEM of six samples (n = 6 animals per group). Data
were analyzed by means of one-way ANOVA followed by Neuman–
Keuls test. Statistical significance *p \ 0.05 versus Saline group
Fig. 6 The effects of acute and chronic 1BnTIQ administration on
the alpha-synuclein level in the substantia nigra, 24 h withdrawal.
1BnTIQ was administered acute or chronic at dose 50 mg/kg i.p.
during 14 consecutive days. The control group was treated with
saline. The rats were decapitated 24 h after last injection. The results
are expressed as the mean ± SEM of six samples (n = 6 animals per
group). Data were analyzed by means of one-way ANOVA followed
by Tukey test. Statistical significance *p \ 0.05; **p \ 0.01 versus
Saline group
Fig. 7 The effects of acute and chronic 1BnTIQ administration on
the tyrosine hydroxylase level in the substantia nigra, 24 h with-
drawal. 1BnTIQ was administered acute or chronic at dose 50 mg/kg
i.p. during 14 consecutive days. The control group was treated with
saline. The rats were decapitated 24 h after last injection. The results
are expressed as the mean ± SEM of six samples (n = 6 animals per
group). Data were analyzed by means of one-way ANOVA followed
by Tukey test. Statistical significance *p \ 0.05; **p \ 0.01 versus
Saline group
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chronic in vivo administration in the rat. The results
demonstrated that chronic (14 days) but not acute admin-
istration of 1BnTIQ (50 mg/kg i.p.) produced a significant
elevation of caspase-3 activity in the rat hippocampus
(Fig. 5), but did not change the level of alpha synuclein
(Fig. 6) or tyrosine hydroxylase (Fig. 7) protein in the rat
substantia nigra. This effect may be caused by low toxicity
of 1BnTIQ or compensatory mechanisms such as an
increase in the expression of TH in the cells survival.
The present data confirm our earlier suggestion that
1BnTIQ is an endogenous neurotoxin with a rather weak
toxicity (Wa˛sik et al. 2009). Only a long-term impact of
this compound or its high concentrations may cause dam-
age of nerve cells. Some authors indicated that 1BnTIQ
dose dependently elevated the level of the pro-apoptotic
protein Bax and simultaneously decreased the concentra-
tion of the antiapoptotic protein Bcl-xl (Shavali and Ebadi
2003). A morphological analysis of SH-SY5Y cells treated
with 1BnTIQ showed nuclear defects and the presence of
apoptotic-like bodies and nuclear fragments (Shavali et al.
2004). Additionally, Kotake et al. (2003) demonstrated that
prolonged exposure of dopaminergic neurons to a low
concentration of 1BnTIQ initially induced a decrease in the
dopamine level, after which the shrinkage of the cell body
led to cell death. These data are in agreement with our
results, in the context of 1BnTIQ neurotoxicity. Some
authors observed that 1BnTIQ caused a significant eleva-
tion of the LDH release only in slices containing mainly
dopaminergic neurons (mesencephalon cultures as well as
co-cultures of mesencephalon and striatum), but in other
regions, the differences were not significant (Kotake et al.
2003). There is a high probability that the differences
between our results compared with other authors’ papers
are due to a low percentage of dopaminergic neurons in the
hippocampal cultures. In the light of those data and taken
into account our present results, we may suggest that
1BnTIQ in a high concentration leads to cell death
via apoptotic route, but may be more toxic for dopami-
nergic cells.
In conclusion, our study strongly indicates that 1BnTIQ
in primary hippocampal cultures may exert opposite effects
on markers of apoptosis depending upon its concentration:
neuroprotection at low concentrations or pro-apoptotic
effect at higher concentrations. However, 1BnTIQ in a high
concentration and upon prolonged exposure leads to
apoptotic cell death and can be one of the etiological fac-
tors of neurodegenerative disease.
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